James Rogers - Cigna Corp Independent Director

CI Stock  USD 363.19  0.15  0.04%   

Director

Mr. James E. Rogers is Independent Director of Cigna Corporationration He has served as Chairman of Duke Energy Corporationrationration, a publicly traded electric power company, from 2007 until 2013 and as the President and Chief Executive Officer from 2006 until 2013. Since October 2016, Mr. Rogers has served as a senior operating partner of Stonepeak Infrastructure Partners, a private equity firm focused on infrastructure investments. He cofounded and has served as Chairman of Brightlight Foundation, a nonprofit provider of globally accessible and affordable energy solutions, since 2011. He was formerly the Chairman, President and Chief Executive Officer of CINERGY Corporationration from 1994 until 2006. Mr. Rogers received his Bachelor of Business Administration from Emory University and his juris doctor from the University of Kentucky. Duke Energy Corporation, Applied Materials, Inc., CINERGY Corporationration, Fifth Third Bancorp since 2007.
Age 69
Tenure 17 years
Address 900 Cottage Grove Road, Bloomfield, CT, United States, 06002
Phone860 226 6000
Webhttps://www.cigna.com
Rogers has extensive senior leadership experience through his positions with Duke Energy and in the utility industry for 25 years. Over the course of his career, he served on the boards of eight Fortune 500 companies. As President and CEO of Duke Energy, he had oversight of financial operations, financial reporting, merger and acquisition activities and corporate restructurings. As a director of Fifth Third Bancorp, a regional banking corporation, Mr. Rogers developed a deeper understanding of several facets of commercial and consumer financial services. Throughout his career at Duke Energy and CINERGY, Mr. Rogers operated in a heavily regulated environment and oversaw and implemented strategic policy initiatives. Before his corporate career, he served as the Deputy General Counsel for the Federal Energy Regulatory Commission and as a partner in the law firm of Akin Gump Strauss Hauer & Feld in Washington, D.C.

Cigna Corp Management Efficiency

The company has Return on Asset (ROA) of 0.0375 % which means that for every $100 of assets, it generated a profit of $0.0375. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.1179 %, which means that it produced $0.1179 on every 100 dollars invested by current stockholders. Cigna Corp's management efficiency ratios could be used to measure how well Cigna Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Cigna Corp's Return On Capital Employed is decreasing as compared to previous years. The Cigna Corp's current Return On Assets is estimated to increase to 0.04, while Return On Equity is projected to decrease to 0.10. As of now, Cigna Corp's Fixed Asset Turnover is increasing as compared to previous years. The Cigna Corp's current Return On Assets is estimated to increase to 0.04, while Total Assets are projected to decrease to under 89 B.
The company reports 31.48 B of total liabilities with total debt to equity ratio (D/E) of 0.74, which is normal for its line of buisiness. Cigna Corp has a current ratio of 0.81, implying that it has not enough working capital to pay out debt commitments in time. Debt can assist Cigna Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Cigna Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cigna Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cigna to invest in growth at high rates of return. When we think about Cigna Corp's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Anat NaschitzMedigus Ltd ADR
N/A
Ramona SequeiraEdwards Lifesciences Corp
55
William LinkEdwards Lifesciences Corp
Yair RabinowitchMedigus Ltd ADR
71
Jeremy StarkweatherMedigus Ltd ADR
42
Yoseph BornsteinMicrobot Medical
65
Eitan MachoverMedigus Ltd ADR
55
Martin MaddenMicrobot Medical
57
Oded YatzkanMedigus Ltd ADR
49
Nicholas ValerianiEdwards Lifesciences Corp
64
Scott BurellMicrobot Medical
52
Leslie HeiszEdwards Lifesciences Corp
60
Yair RabinovitchMedigus Ltd ADR
67
Martha MarshEdwards Lifesciences Corp
72
Ori HershkovitzMedigus Ltd ADR
39
Yuval YanaiMedigus Ltd ADR
65
Steven LorangerEdwards Lifesciences Corp
69
Erez HaimovitzMedigus Ltd ADR
N/A
Yoav WaizerMicrobot Medical
51
Aviel ShapiraMedigus Ltd ADR
61
Alfred LimEUDA Health Holdings
72
Cigna Corporation provides insurance and related products and services in the United States. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut. Cigna Corp operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 72226 people. Cigna Corp (CI) is traded on New York Stock Exchange in USA. It is located in 900 Cottage Grove Road, Bloomfield, CT, United States, 06002 and employs 70,325 people. Cigna Corp is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

Cigna Corp Leadership Team

Elected by the shareholders, the Cigna Corp's board of directors comprises two types of representatives: Cigna Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cigna. The board's role is to monitor Cigna Corp's management team and ensure that shareholders' interests are well served. Cigna Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cigna Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nicole Jones, Executive Vice President, General Counsel
Donna Zarcone, Independent Director
Herbert Fritch, President of Cigna-Healthspring
John Webb, President - Health Care
Alexis Jones, Investor Principal
Neesha Hathi, Independent Director
David Guilmette, President - Global Employer Segment
James Rogers, Independent Director
Eric Foss, Independent Director
William Zollars, Independent Director
ALAN MUNEY, Executive Vice President Total Health & Network and Chief Medical Officer
John Murabito, Executive Vice President - Human Resources, Chief Administrative Officer
Christopher MBA, President Businesses
Edwin Detrick, Vice President - Investor Relations
Roman Martinez, Independent Director
Ralph Giacobbe, Senior Relations
Phil Austin, Head Markets
Jane Henney, Independent Director
Elder Granger, Independent Director
Kimberly Ross, Independent Director
Brian Evanko, Chief Financial Officer, Executive Vice President
Matt Perlberg, Pharmacy President
Kari Stevens, Chief VP
David Cordani, CEO and President Director and Member of Executive Committee
Charles Berg, President - U.S. Government Business
Mary Hoeltzel, Director
Arjan Toor, Chief Operations
Matthew Manders, President of U.S. Commercial Markets and Global Health Care Operations
Timothy, Director
Greg Allen, President of Tennessee Market
Noelle Eder, Executive Vice President, Global Chief Information Officer
Eric Palmer, Chief Financial Officer, Executive Vice President
Dean Mirabella, President Markets
Cynthia Ryan, Chief Human Resource Officer
Brain Evanko, President Government Business
Mark Boxer, Executive Vice President, Chief Information Officer
Adam PharmD, President Services
Jason Sadler, President of International Markets
Timothy Wentworth, Chief Executive Officer - Evernorth
Michael Phillips, President and General Manager - Midwest Market
Lisa Bacus, Executive Vice President, Chief Marketing Officer, Chief Customer Officer
Isaiah Harris, Independent Chairman of the Board
William DeLaney, Independent Director
Thomas McCarthy, CFO and Executive VP
Kristen Lauria, Executive Vice President, Chief Marketing Officer
Everett Neville, Executive Vice President, Strategy, Corporate Development and Solutions
Paul Sanford, Executive Vice President - Operations
John Partridge, Independent Director
William McDowell, Vice President Investor Relations
Michelle Gass, Independent Director
Mark McClellan, Independent Director
Kathleen Mazzarella, Independent Director
Mary CPA, Senior Officer
MICHAEL TRIPLETT, President - U.S. Commercial
Steven Miller, Executive Vice President Chief Clinical Officer
Mary Picerno, Chief Officer
Eric Wiseman, Lead Independent Director
CHRISTOPHER HOCEVAR, President Strategy, Segments and Solutions
William Roper, Independent Director
George Kurian, Independent Director

Cigna Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cigna Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Cigna Corp Investors Sentiment

The influence of Cigna Corp's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Cigna. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Cigna Corp's public news can be used to forecast risks associated with an investment in Cigna. The trend in average sentiment can be used to explain how an investor holding Cigna can time the market purely based on public headlines and social activities around Cigna Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Cigna Corp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cigna Corp's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Cigna Corp's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Cigna Corp.

Cigna Corp Implied Volatility

    
  35.95  
Cigna Corp's implied volatility exposes the market's sentiment of Cigna Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cigna Corp's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cigna Corp stock will not fluctuate a lot when Cigna Corp's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cigna Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cigna Corp's short interest history, or implied volatility extrapolated from Cigna Corp options trading.

Pair Trading with Cigna Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cigna Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cigna Corp will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cigna Stock

  0.76RNLX Renalytix AI Report 4th of April 2024 PairCorr

Moving against Cigna Stock

  0.81MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.8KA Kineta Inc Report 29th of March 2024 PairCorr
  0.72MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.7TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.66MASS 908 Devices Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Cigna Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cigna Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cigna Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cigna Corp to buy it.
The correlation of Cigna Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cigna Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cigna Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cigna Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cigna Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cigna Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cigna Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cigna Corp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cigna Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Cigna Stock analysis

When running Cigna Corp's price analysis, check to measure Cigna Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cigna Corp is operating at the current time. Most of Cigna Corp's value examination focuses on studying past and present price action to predict the probability of Cigna Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cigna Corp's price. Additionally, you may evaluate how the addition of Cigna Corp to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Global Correlations
Find global opportunities by holding instruments from different markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is Cigna Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cigna Corp. If investors know Cigna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cigna Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.10)
Dividend Share
4.92
Earnings Share
17.39
Revenue Per Share
664.145
Quarterly Revenue Growth
0.116
The market value of Cigna Corp is measured differently than its book value, which is the value of Cigna that is recorded on the company's balance sheet. Investors also form their own opinion of Cigna Corp's value that differs from its market value or its book value, called intrinsic value, which is Cigna Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cigna Corp's market value can be influenced by many factors that don't directly affect Cigna Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cigna Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cigna Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cigna Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.